Inventor · disambiguated record
John D. Hoekman
Also filed as: HOEKMAN JOHN D
21 granted patents·16 pending applications·74 citations·filing 2007–2023
93Inventor score
Files withIMPEL NEUROPHARMA INC14IMPEL PHARMACEUTICALS INC12HOEKMAN JOHN D2UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION2HANSOM LEAH R1
Top patents by PatentIndex Score
37 records- 0189US9550036B2Nasal drug delivery deviceIMPEL NEUROPHARMA INC·Filed 2013·Granted Jan 24, 2017·25 cites·61 claims
- 0288US11185497B2Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2020·Granted Nov 30, 2021·2 cites·5 claims
- 0385US11191910B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2019·Granted Dec 7, 2021·5 cites·20 claims
- 0483US10507295B2Nasal drug delivery deviceIMPEL NEUROPHARMA INC·Filed 2016·Granted Dec 17, 2019·4 cites·27 claims
- 0581US11007332B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2017·Granted May 18, 2021·2 cites·12 claims
- 0680US11278492B2Intranasal delivery of olanzapine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Granted Mar 22, 2022·1 cites·24 claims
- 0780US2024075223A1Nozzles for Nasal Drug DeliveryLMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0879US8757146B2Circumferential aerosol deviceHOEKMAN JOHN D·Filed 2009·Granted Jun 24, 2014·24 cites·2 claims
- 0978US2024115819A1In-Line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1077US2024181183A1Nasal drug delivery deviceJN BIDCO LLC·Filed 2023·Application pending·0 cites
- 1175US11266799B2In-line nasal delivery deviceIMPEL NEUROPHARMA INC·Filed 2016·Granted Mar 8, 2022·2 cites·12 claims
- 1275US2023241334A1In-line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1374US11730903B2Nasal drug delivery deviceIMPEL PHARMACEUTICALS INC·Filed 2019·Granted Aug 22, 2023·1 cites·20 claims
- 1473US2023364010A1Intranasal delivery of olanzapine by precision olfactory deviceIMPEL PHARMCEUTICALS INC·Filed 2023·Application pending·0 cites
- 1572US11890412B2Nozzles for nasal drug deliveryIMPEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 6, 2024·0 cites·18 claims
- 1672US2023095719A1In-line Nasal Delivery DeviceIMPEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1771US11752100B2Intranasal delivery of olanzapine by precision olfactory deviceIMPEL PHARMACEUTICALS INC·Filed 2022·Granted Sep 12, 2023·0 cites·33 claims
- 1871US2024252489A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesWOODWARD SPECIALTY LLC·Filed 2023·Application pending·0 cites
- 1970US2023301955A1Respiratory tract delivery of levodopa and dopa decarboxylase inhibitor for treatment of parkinson's diseaseIMPEL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2069US11690819B2Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's diseaseIMPEL PHARMACEUTICALS INC·Filed 2022·Granted Jul 4, 2023·0 cites·18 claims
- 2169US9919117B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2013·Granted Mar 20, 2018·3 cites·14 claims
- 2268US11517548B2Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's DiseaseIMPEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 6, 2022·0 cites·15 claims
- 2368US2022105030A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 2465US10016582B2Circumferential aerosol deviceUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted Jul 10, 2018·2 cites·7 claims
- 2562US10537692B2Medical unit dose containerIMPEL NEUROPHARMA INC·Filed 2014·Granted Jan 21, 2020·2 cites·20 claims
- 2662US9480649B2Lipid microparticle growth factor formulationsHANSOM LEAH R·Filed 2007·Granted Nov 1, 2016·1 cites·66 claims
- 2761US2018296813A1Circumferential aerosol deviceUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2018·Application pending·0 cites
- 2860US10940278B2Nozzles for nasal drug deliveryIMPEL NEUROPHARMA INC·Filed 2018·Granted Mar 9, 2021·0 cites·17 claims
- 2958US2021236485A1Repeated administration of dihydroergotamine for treatment of frequent migraine headachesIMPEL NEUROPHARMA INC·Filed 2021·Application pending·0 cites
- 3056US2019209463A1Intranasal delivery of dihydroergotamine by precision olfactory deviceIMPEL NEUROPHARMA INC·Filed 2019·Application pending·0 cites
- 3154US11207430B2Gadolinium expressed lipid nanoparticles for magnetic resonance imagingUNIV WASHINGTON·Filed 2016·Granted Dec 28, 2021·0 cites·7 claims
- 3254US2022296504A1Intranasal delivery of levodopa powder by precision olfactory deviceIMPEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3349US11878109B2Single-use nasal delivery deviceIMPEL PHARMACEUTICALS INC·Filed 2020·Granted Jan 23, 2024·0 cites·20 claims
- 3447US11759585B2Nasal drug delivery device with detachable nozzleIMPEL PHARMACEUTICALS INC·Filed 2019·Granted Sep 19, 2023·0 cites·25 claims
- 3544US2015100042A1Muroid Family Nasal DeviceIMPEL NEUROPHARMA INC·Filed 2014·Application pending·0 cites
- 3636US2013142868A1Circumferential Aerosol Device for Delivering Drugs to Olfactory Epithelium and BrainHOEKMAN JOHN D·Filed 2011·Application pending·0 cites
- 3733US2012087857A1Gadolinium expressed lipid nanoparticles for magnetic resonance imagingHO RODNEY J Y·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John D. Hoekman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →